Cargando…
Basic and Clinical Pharmaco-Therapeutics of SGLT2 Inhibitors: A Contemporary Update
Clinical relevance of sodium/glucose cotransporter 2 (SGLT2) inhibitors has been rapidly evolving across several therapy areas, apart from type 2 diabetes mellitus. While some of these developments are based on recognized scientific explanations, unexpected study findings have also shaped much of ou...
Autores principales: | Kalra, Sanjay, Shetty, Kimi K., Nagarajan, Vertivel B., Ved, Jignesh K. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Healthcare
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7136386/ https://www.ncbi.nlm.nih.gov/pubmed/32130664 http://dx.doi.org/10.1007/s13300-020-00789-y |
Ejemplares similares
-
Sodium-glucose Cotransporter 2 Inhibitor Use: A Pharmaco-ergonomic Qualification Tool
por: Kalra, Sanjay, et al.
Publicado: (2017) -
Sodium Glucose Co-Transporter-2 (SGLT2) Inhibitors: A Review of Their Basic and Clinical Pharmacology
por: Kalra, Sanjay
Publicado: (2014) -
Erratum to: Sodium Glucose Co-Transporter-2 (SGLT2) Inhibitors: A Review of Their Basic and Clinical Pharmacology
por: Kalra, Sanjay
Publicado: (2015) -
PHARMACO – THERAPEUTICS OF DASEMANI DRUGS
por: Sircar, N. N.
Publicado: (1984) -
Diabetes Destiny in our Hands: Achieving Metabolic Karma
por: Kalra, Sanjay, et al.
Publicado: (2017)